Canada - English - Health Canada

pge canada (86) inc. - linoleic acid; alpha-linolenic acid; vitamin e (d-alpha tocopheryl acetate); gamma-linolenic acid - capsule - 216mg; 1mg; 10unit; 90mg - linoleic acid 216mg; alpha-linolenic acid 1mg; vitamin e (d-alpha tocopheryl acetate) 10unit; gamma-linolenic acid 90mg - vitamin e

Canada - English - Health Canada

pge canada (86) inc. - linoleic acid; gamma-linolenic acid; vitamin e (d-alpha tocopheryl acetate) - capsule - 378mg; 240mg; 10unit - linoleic acid 378mg; gamma-linolenic acid 240mg; vitamin e (d-alpha tocopheryl acetate) 10unit - vitamin e

United States - English - NLM (National Library of Medicine)

vedco, inc. - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - carprofen 25 mg - novox is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. novox should not be used in dogs exhibiting previous hypersensitivity to carprofen.

United States - English - NLM (National Library of Medicine)

vedco, inc. - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - carprofen 25 mg - novox® is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. carprofen should not be used in dogs exhibiting previous hypersensitivity to carprofen.

United States - English - NLM (National Library of Medicine)

vedco, inc - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - indications: novox is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. contraindications: novox should not be used in dogs exhibiting previous hypersensitivity to carprofen.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - celecoxib (unii: jcx84q7j1l) (celecoxib - unii:jcx84q7j1l) - celecoxib capsules are indicated for the management of the signs and symptoms of oa [see clinical studies (14.1) ] for the management of the signs and symptoms of ra [see clinical studies (14.2) ] for the management of the signs and symptoms of jra in patients 2 years and older [see clinical studies (14.3) ] for the management of the signs and symptoms of as [see clinical studies (14.4) ] for the management of acute pain in adults [see clinical studies (14.5) ] for the management of primary dysmenorrhea [see clinical studies (14.5) ] celecoxib capsules are contraindicated in the following patients: pregnancy category c. pregnancy category d from 30 weeks of gestation onward. risk summary use of nsaids, including celecoxib capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including celecoxib capsules, in pregnant women starting at 30 weeks of gestation. there are no adequate and well-controlled studies of cele

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - diphenhydramine hydrochloride 50mg - liquid filled capsule - 50 mg - active: diphenhydramine hydrochloride 50mg excipient: brilliant blue fcf gelatin glycerol macrogol 400 opacode white nsp-78-18022 purified water sorbitol - unisom sleepgels are used as a night time sleep aid for the short-management of insomnia.

Canada - English - Health Canada

merck frosst canada & cie, merck frosst canada & co. - rofecoxib - tablet - 12.5mg - rofecoxib 12.5mg - cyclooxygenase-2 (cox-2) inhibitors

Canada - English - Health Canada

merck frosst canada & cie, merck frosst canada & co. - rofecoxib - tablet - 25mg - rofecoxib 25mg - cyclooxygenase-2 (cox-2) inhibitors

Canada - English - Health Canada

merck frosst canada & cie, merck frosst canada & co. - rofecoxib - suspension - 12.5mg - rofecoxib 12.5mg - cyclooxygenase-2 (cox-2) inhibitors